Document is current
Any future updates will be listed below
-
Authors
Gordon, Joshua A. https://orcid.org/0000-0002-5488-8266
Veenstra-VanderWeele, Jeremy
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD109879)
- License Information
-
More Information
Article History
Received: 30 June 2025
Revised: 4 August 2025
Accepted: 11 August 2025
First Online: 5 September 2025
Change Date: 12 September 2025
Change Type: Update
Change Details: Funding has been removed from the article.
Competing interests
: JAG has no competing interests to report. JV-VW has consulted or served on an advisory board for Roche Pharmaceuticals, Novartis, SynapDx, the Simons Foundation, the Coalition for Aligning Science, Autism Speaks, and the Brain and Behavior Research Foundation. He has received research funding from Roche Pharmaceuticals, Novartis, SynapDx, Seaside Therapeutics, Janssen, Yamo Pharmaceuticals, MapLight, Acadia, Forest, the Simons Foundation, the Department of Defense, and the National Institute of Health. He has received an editorial stipend from Springer and Wiley.
